In summary, the present study showed that PCB 126 induced NASH through increased inflammatory processes, impairment of lipid oxidation, and development of hepatic steatosis associated with increased expression of proinflammatory cytokines, reduced expression of PPARα, and upregulation of miR-155 and miR-34a in the liver. Here, PPARA is linked to fatty liver disease.